Skip to main content
. 2012 Jul 26;1(1):93–99. doi: 10.3892/mco.2012.4

Table I.

Exposure conditions in CD-DST.

Drug Concentration (μg/ml) Exposure time (h) Clinical dose (mg/m2) AUC (in vitro/human)a
ADM 0.02 24 60 0.98
EPI 0.1 24 40 1.20
DOC 0.1 24 60 0.83
PTX 1.0 24 210 1.03
a

1.0, same as clinical AUC. ADM, adriamycin; EPI, epirubicin; DOC, docetaxel; PTX, paclitaxel; AUC, area under the drug concentration-time curve.